Clinical Trial Update: Intracoronary or Intravenous Infusion Human Wharton' Jelly-derived Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating intracoronary or intravenous infusion of human Wharton's jelly-derived mesenchymal stem cells in patients with ischemic car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Cardiomyopathy

Drugs mentioned

• Wharton's Jelly Derived Mesenchymal Stem Cells (mesenchymal stem cells)

Snippet

Sponsor: Navy General Hospital, Beijing | Conditions: Ischemic Cardiomyopathy | Phase 2 | Status: UNKNOWN